Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Merz Investigative Site # 001055
mi
from
Bedford, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Merz Investigative Site # 001055
mi
from
Bedford, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Bedford, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Bedford, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Dallas, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Dallas, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Edinburg, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Edinburg, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Houston, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
San Antonio, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Tyler, TX
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Alexandria, VA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Fishersville, VA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Fishersville, VA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Virginia Beach, VA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Auburn, WA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Auburn, WA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Kirkland, WA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Spokane, WA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
Clinical Research Facility
mi
from
Morgantown, WV
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
Lipoic Acid for Chronic Inflammatory Demyelinating Polyneuropathy—A Randomized, Double-Blind, Placebo Controlled Pilot Study
Status: Enrolling
Updated:  11/9/2012
Oregon Health and Science University
mi
from
Portland, OR
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
Lipoic Acid for Chronic Inflammatory Demyelinating Polyneuropathy—A Randomized, Double-Blind, Placebo Controlled Pilot Study
Status: Enrolling
Updated: 11/9/2012
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Effects of Pennsaid on Clinical Neuropathic Pain
Effects of Pennsaid on Clinical Neuropathic Pain
Status: Enrolling
Updated:  11/9/2012
MGH Center for Translational Pain Research
mi
from
Boston, MA
Effects of Pennsaid on Clinical Neuropathic Pain
Effects of Pennsaid on Clinical Neuropathic Pain
Status: Enrolling
Updated: 11/9/2012
MGH Center for Translational Pain Research
mi
from
Boston, MA
Click here to add this to my saved trials
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Status: Enrolling
Updated:  11/13/2012
Columbia University Medical Center
mi
from
New York, NY
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Status: Enrolling
Updated: 11/13/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Fayetteville, AR
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative site
mi
from
Los Angeles, CA
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Miami, FL
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Chicago, IL
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Louisville, KY
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Ann Arbor, MI
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Las Vegas, NV
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Brick, NJ
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Brick, NJ
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Bismark, ND
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Bismark, ND
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Cincinatti, OH
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Cincinatti, OH
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Oklahoma City, OK
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Blue Bell, PA
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Blue Bell, PA
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative site
mi
from
Dallas, TX
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated:  11/13/2012
Novartis Investigative Site
mi
from
Spokane, WA
Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
A 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in the Treatment of Adult Patients With Childhood-onset ADHD
Status: Enrolling
Updated: 11/13/2012
Novartis Investigative Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of Arizona
mi
from
Tucson, AZ
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of California San Francisco and affiliated hospitals
mi
from
San Francisco, CA
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of California San Francisco and affiliated hospitals
mi
from
San Francisco, CA
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Stanford Medical Center
mi
from
Stanford, CA
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Stanford Medical Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of Miami
mi
from
Miami, FL
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
The Villages Research Group
mi
from
Ocala, FL
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
The Villages Research Group
mi
from
Ocala, FL
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of Kentucky
mi
from
Lexington, KY
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Henry Ford Hospital and affiliated hospitals
mi
from
Detroit, MI
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Henry Ford Hospital and affiliated hospitals
mi
from
Detroit, MI
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Wayne State and affiliated hospitals
mi
from
Detroit, MI
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Wayne State and affiliated hospitals
mi
from
Detroit, MI
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of Minnesota and affiliated hospitals
mi
from
Minneapolis, MN
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of Minnesota and affiliated hospitals
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University Hospital and affiliated hospitals
mi
from
Cincinnati, OH
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University Hospital and affiliated hospitals
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
Oregon Health Science University and affiliated sites
mi
from
Portland, OR
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
Oregon Health Science University and affiliated sites
mi
from
Portland, OR
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of Pennsylvania - Abington Hospital
mi
from
Abington, PA
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of Pennsylvania - Abington Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated:  11/14/2012
University of Texas - Memorial Hermann
mi
from
Houston, TX
Albumin in Acute Ischemic Stroke Trial
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Status: Enrolling
Updated: 11/14/2012
University of Texas - Memorial Hermann
mi
from
Houston, TX
Click here to add this to my saved trials